Musa I, Wang Z, Yang N, Li X
Front Immunol. 2024; 15:1427563.
PMID: 39221239
PMC: 11363073.
DOI: 10.3389/fimmu.2024.1427563.
Guo S, Tian Y, Li J, Zeng X
Int J Mol Sci. 2024; 25(12).
PMID: 38928233
PMC: 11203527.
DOI: 10.3390/ijms25126528.
Zhou Y, Wei X, Jia L, Li W, Zhang S, Zhao Y
Biochem Genet. 2024; .
PMID: 38649557
DOI: 10.1007/s10528-024-10794-6.
Lee E, Oh J
Front Immunol. 2024; 15:1328785.
PMID: 38426103
PMC: 10902158.
DOI: 10.3389/fimmu.2024.1328785.
Xu H, He X
Front Immunol. 2024; 14:1242478.
PMID: 38274798
PMC: 10808336.
DOI: 10.3389/fimmu.2023.1242478.
Predictive value of soluble CD40L combined with APACHE II score in elderly patients with sepsis in the emergency department.
Yang L, Yang J, Zhang X, Ye X, Liu Y, Wei B
BMC Anesthesiol. 2024; 24(1):32.
PMID: 38243164
PMC: 10797713.
DOI: 10.1186/s12871-023-02381-w.
Reduced Relapse-Free Survival in Colorectal Cancer Patients with Elevated Soluble CD40 Ligand Levels Improved by Vitamin D Supplementation.
Fujimoto H, Fukuzato S, Kanno K, Akutsu T, Ohdaira H, Suzuki Y
Nutrients. 2023; 15(20).
PMID: 37892436
PMC: 10609672.
DOI: 10.3390/nu15204361.
Thromboinflammatory challenges in stroke pathophysiology.
Szepanowski R, Haupeltshofer S, Vonhof S, Frank B, Kleinschnitz C, Casas A
Semin Immunopathol. 2023; 45(3):389-410.
PMID: 37273022
PMC: 10241149.
DOI: 10.1007/s00281-023-00994-4.
Comparative transcriptome analysis of and C3H mice infected with the Lyme disease pathogen.
Gaber A, Mandric I, Nitirahardjo C, Piontkivska H, Hillhouse A, Threadgill D
Front Cell Infect Microbiol. 2023; 13:1115350.
PMID: 37113133
PMC: 10126474.
DOI: 10.3389/fcimb.2023.1115350.
Targeting immune checkpoints in anti-neutrophil cytoplasmic antibodies associated vasculitis: the potential therapeutic targets in the future.
Pan M, Zhao H, Jin R, Leung P, Shuai Z
Front Immunol. 2023; 14:1156212.
PMID: 37090741
PMC: 10115969.
DOI: 10.3389/fimmu.2023.1156212.
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing.
Castiello M, Ferrari S, Villa A
Semin Immunol. 2023; 66:101731.
PMID: 36863140
PMC: 10109147.
DOI: 10.1016/j.smim.2023.101731.
Platelet signaling at the nexus of innate immunity and rheumatoid arthritis.
Jiang S, To J, Hughes M, McNagny K, Kim H
Front Immunol. 2022; 13:977828.
PMID: 36505402
PMC: 9732516.
DOI: 10.3389/fimmu.2022.977828.
Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment.
Ho M, Xiao A, Yi D, Zanwar S, Bianchi G
Curr Oncol. 2022; 29(11):8975-9005.
PMID: 36421358
PMC: 9689284.
DOI: 10.3390/curroncol29110705.
Mechanisms of CD40-dependent cDC1 licensing beyond costimulation.
Wu R, Ohara R, Jo S, Liu T, Ferris S, Ou F
Nat Immunol. 2022; 23(11):1536-1550.
PMID: 36271147
PMC: 9896965.
DOI: 10.1038/s41590-022-01324-w.
Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.
Zhang Y, Wu X, Sharma A, Weiher H, Schmid M, Kristiansen G
Front Immunol. 2022; 13:925633.
PMID: 36091050
PMC: 9453234.
DOI: 10.3389/fimmu.2022.925633.
B-cell response in solid organ transplantation.
Yi S, Gaber A, Chen W
Front Immunol. 2022; 13:895157.
PMID: 36016958
PMC: 9395675.
DOI: 10.3389/fimmu.2022.895157.
The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring "Multiple Myelomas".
Solimando A, Da Via M, Bolli N, Steinbrunn T
Cancers (Basel). 2022; 14(13).
PMID: 35805041
PMC: 9265748.
DOI: 10.3390/cancers14133271.
DCs at the center of help: Origins and evolution of the three-cell-type hypothesis.
Wu R, Murphy K
J Exp Med. 2022; 219(7).
PMID: 35543702
PMC: 9098650.
DOI: 10.1084/jem.20211519.
Thyroid eye disease: From pathogenesis to targeted therapies.
Yoon J, Kikkawa D
Taiwan J Ophthalmol. 2022; 12(1):3-11.
PMID: 35399971
PMC: 8988977.
DOI: 10.4103/tjo.tjo_51_21.
Engaging innate immunity in HIV-1 cure strategies.
Board N, Moskovljevic M, Wu F, Siliciano R, Siliciano J
Nat Rev Immunol. 2021; 22(8):499-512.
PMID: 34824401
DOI: 10.1038/s41577-021-00649-1.